Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2020-10-03
DOI
10.1080/17512433.2020.1832889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure analysis of the receptor binding of 2019-nCoV
- (2020) Yun Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- (2020) Elissa Driggin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Potential for Tetracyclines in the Treatment of COVID‐19
- (2020) Mohit Sodhi et al. PHARMACOTHERAPY
- “Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
- (2020) Alexandre Gérard et al. THERAPIE
- Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
- (2020) Su-Jin Park et al. mBio
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
- (2020) Catrin Sohrabi et al. International Journal of Surgery
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
- (2020) Matthieu Million et al. Travel Medicine and Infectious Disease
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management
- (2020) Giovanni Diana et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine – from HIV-1 infection to COVID-19
- (2020) Sara Naghipour et al. Expert Review of Anti-Infective Therapy
- Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges
- (2020) Harmanjit Singh et al. Expert Review of Anti-Infective Therapy
- Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
- (2020) Samia Arshad et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia
- (2020) Christopher Stremmel et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations
- (2020) Shiv Bharadwaj et al. LIFE SCIENCES
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
- (2018) Mario Mauthe et al. Autophagy
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
- (2018) Young Choi et al. Biomed Research International
- Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion
- (2017) Judith M. Phillips et al. JOURNAL OF VIROLOGY
- Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
- (2015) K. D. Rainsford et al. INFLAMMOPHARMACOLOGY
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chemically Modified Tetracycline 3 Prevents Acute Respiratory Distress Syndrome in a Porcine Model of Sepsis + Ischemia/Reperfusion–Induced Lung Injury
- (2012) Shreyas K. Roy et al. SHOCK
- Minocycline attenuates ischemia-induced ventricular arrhythmias in rats
- (2011) Xiaorong Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Minocycline Suppresses Activation of Nuclear Factor of Activated T Cells 1 (NFAT1) in Human CD4+T Cells
- (2011) Gregory L. Szeto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The prospects of minocycline in multiple sclerosis
- (2011) Xiaohong Chen et al. JOURNAL OF NEUROIMMUNOLOGY
- Jack of all trades: Pleiotropy and the application of chemically modified tetracycline-3 in sepsis and the acute respiratory distress syndrome (ARDS)
- (2011) Shreyas K. Roy et al. PHARMACOLOGICAL RESEARCH
- A Tetracycline Analog Improves Acute Respiratory Distress Syndrome Survival in an Ovine Model
- (2010) Xiaoqin Zhou et al. ANNALS OF THORACIC SURGERY
- Minocycline Attenuates HIV Infection and Reactivation by Suppressing Cellular Activation in Human CD4+T Cells
- (2010) Gregory L. Szeto et al. JOURNAL OF INFECTIOUS DISEASES
- Minocycline and neurodegenerative diseases
- (2008) Hye-Sun Kim et al. BEHAVIOURAL BRAIN RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More